Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.700
-0.040 (-2.30%)
Oct 10, 2025, 11:20 AM EDT - Market open
Ovid Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Cash & Equivalents | 28.42 | 26.3 | 27.04 | 44.87 | 187.8 | 72.03 | Upgrade |
Short-Term Investments | 9.93 | 26.77 | 78.79 | 84.13 | - | - | Upgrade |
Cash & Short-Term Investments | 38.35 | 53.08 | 105.83 | 129 | 187.8 | 72.03 | Upgrade |
Cash Growth | -50.18% | -49.85% | -17.96% | -31.31% | 160.71% | -6.13% | Upgrade |
Other Receivables | - | - | - | - | - | 0.14 | Upgrade |
Total Trade Receivables | - | - | - | - | - | 0.14 | Upgrade |
Other Current Assets | 3.74 | 2.87 | 3.76 | 2.38 | 2.68 | 2.67 | Upgrade |
Total Current Assets | 42.09 | 55.94 | 109.6 | 131.38 | 190.48 | 74.84 | Upgrade |
Net Property, Plant & Equipment | 12.5 | 13.23 | 14.66 | 16.07 | 0.24 | 0.14 | Upgrade |
Long-Term Investments | 20.91 | 20.97 | 17.63 | 5.62 | 1.63 | - | Upgrade |
Other Long-Term Assets | 1.93 | 2.02 | 2.14 | 2.19 | 2.19 | 0.95 | Upgrade |
Total Assets | 77.43 | 92.17 | 144.03 | 155.27 | 194.54 | 75.93 | Upgrade |
Accounts Payable | 3.95 | 3.19 | 3.7 | 1.95 | 7.13 | 5.45 | Upgrade |
Accrued Expenses | 2.87 | 5.99 | 6.52 | 4.5 | 7.67 | 12.03 | Upgrade |
Current Portion of Leases | 1.38 | 1.34 | 1.25 | 0.53 | - | - | Upgrade |
Unearned Revenue | 0.72 | - | - | - | - | 2.21 | Upgrade |
Other Current Liabilities | - | - | - | - | - | 2.37 | Upgrade |
Total Current Liabilities | 8.92 | 10.52 | 11.47 | 6.99 | 14.8 | 22.06 | Upgrade |
Long-Term Leases | 12.72 | 13.42 | 14.76 | 16 | - | - | Upgrade |
Other Long-Term Liabilities | - | - | 30 | - | - | 10.23 | Upgrade |
Total Long-Term Liabilities | 12.72 | 13.42 | 44.76 | 16 | - | 10.23 | Upgrade |
Total Liabilities | 21.64 | 23.94 | 56.23 | 22.99 | 14.8 | 32.29 | Upgrade |
Preferred Stock | - | - | - | 0 | 0 | 0 | Upgrade |
Common Stock | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade |
Additional Paid-in Capital | 375.01 | 372.49 | 365.59 | 357.77 | 351.03 | 337.76 | Upgrade |
Accumulated Other Comprehensive Income | -0.07 | -0.04 | 0 | -0.04 | - | - | Upgrade |
Retained Earnings | -319.22 | -304.3 | -277.87 | -225.53 | -171.36 | -294.19 | Upgrade |
Total Common Shareholders' Equity | 55.79 | 68.23 | 87.8 | 132.27 | 179.75 | 43.63 | Upgrade |
Shareholders' Equity | 55.79 | 68.23 | 87.8 | 132.27 | 179.75 | 43.63 | Upgrade |
Total Liabilities & Equity | 77.43 | 92.17 | 144.03 | 155.27 | 194.54 | 75.93 | Upgrade |
Total Debt | 14.1 | 14.76 | 16 | 16.54 | 0 | 0 | Upgrade |
Net Cash (Debt) | 24.25 | 38.32 | 89.83 | 112.47 | 187.8 | 72.03 | Upgrade |
Net Cash Growth | -36.72% | -57.34% | -20.13% | -40.11% | 160.71% | -6.13% | Upgrade |
Net Cash Per Share | 0.34 | 0.54 | 1.27 | 1.60 | 2.76 | 1.23 | Upgrade |
Book Value | 55.79 | 68.23 | 87.8 | 132.27 | 179.75 | 43.63 | Upgrade |
Book Value Per Share | 0.79 | 0.96 | 1.24 | 1.88 | 2.64 | 0.75 | Upgrade |
Tangible Book Value | 55.79 | 68.23 | 87.8 | 132.27 | 179.75 | 43.63 | Upgrade |
Tangible Book Value Per Share | 0.79 | 0.96 | 1.24 | 1.88 | 2.64 | 0.75 | Upgrade |
Updated Aug 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.